LEPRI, GEMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.489
EU - Europa 779
AS - Asia 223
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.485
PL - Polonia 236
IE - Irlanda 167
IT - Italia 157
SE - Svezia 115
HK - Hong Kong 90
CN - Cina 53
JO - Giordania 31
IN - India 25
RU - Federazione Russa 22
DE - Germania 19
FI - Finlandia 17
GB - Regno Unito 17
VN - Vietnam 14
CH - Svizzera 10
SG - Singapore 9
ES - Italia 6
CA - Canada 4
BE - Belgio 3
FR - Francia 3
UA - Ucraina 3
RO - Romania 2
AT - Austria 1
AU - Australia 1
EU - Europa 1
MK - Macedonia 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.494
Salva come PNG Salva come JPEG
Città #
Fairfield 244
Warsaw 232
Dublin 164
Chandler 155
Ashburn 154
Woodbridge 116
Seattle 102
Cambridge 95
Houston 80
Wilmington 69
Lawrence 60
Altamura 58
Hong Kong 50
Princeton 50
Florence 44
Ann Arbor 39
Beijing 39
Boston 36
Moscow 22
Pune 22
Buffalo 13
Dong Ket 12
San Diego 12
Boardman 10
Falls Church 9
Norwalk 9
Shanghai 9
Singapore 9
Bern 8
New York 8
West Jordan 8
Andover 6
Barcelona 6
Medford 6
Düsseldorf 4
Hillsboro 4
Scandicci 4
Brussels 3
Castelliri 3
London 3
Polska 3
Redwood City 3
Rome 3
Toronto 3
Hamburg 2
Iesi 2
Jacksonville 2
Malmo 2
Naples 2
Novara 2
Phoenix 2
Pinerolo 2
Reggello 2
Salerno 2
Sesto Fiorentino 2
Washington 2
Acton 1
Arnsberg 1
Augusta 1
Bremen 1
Bucharest 1
Casalnuovo 1
Cattolica 1
Chennai 1
Chiswick 1
Guangzhou 1
Gunzenhausen 1
Horben 1
Laurel 1
Ludwigshafen am Rhein 1
Mahé 1
Mascalucia 1
Milan 1
Napoli 1
Paris 1
Redmond 1
Sydney 1
Taipei 1
Tappahannock 1
Trumbull 1
Ulez 1
Uzzano 1
Vienna 1
Winnipeg 1
Zhengzhou 1
Totale 2.042
Salva come PNG Salva come JPEG
Nome #
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 220
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 160
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 119
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 117
AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) 101
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 96
The safety of iloprost in systemic sclerosis in a real-life experience 88
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 84
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 81
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 80
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 76
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 75
SAT0505 Severe Vitamin D Deficiency in Patients with Kawasaki Disease: its Possible Role in the Risk to Develop Coronary Artery Damage 73
The renal resistive index, a new biomarker for the follow up of vascular modifications in Systemic Sclerosis 72
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 69
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 68
Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? 63
Effects of rituximab in connective tissue disorders related interstitial lung disease 57
PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis 55
Antioxidant agents help primary Raynaud's phenomenon 53
Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections 51
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 45
Prognostic value of lung ultrasound B-lines in systemic sclerosis 41
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 40
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 40
AB0481 Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Onset Systemic Lupus Erythematosus: A Transversal Study 39
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 38
Stressful life events at the onset and during the evolution of systemic sclerosis 36
Oral lactobacillus species in systemic sclerosis 35
Very early and early diagnosis of systemic sclerosis 34
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 34
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 32
Early diagnosis of systemic sclerosis, where do we stand today? 31
Recent advances steer the future of systemic sclerosis toward precision medicine 30
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 30
Systemic sclerosis and primary biliary cholangitis: An overlapping entity? 29
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 27
Systemic Sclerosis Association with Malignancy 23
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 19
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 19
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 18
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 18
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 17
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 16
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 15
One year in review 2021: systemic sclerosis 12
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 10
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 3
Systemic sclerosis: one year in review 2022 2
Totale 2.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019136 0 0 0 0 0 0 0 0 0 28 53 55
2019/2020448 25 22 12 27 50 49 49 51 50 37 67 9
2020/2021471 24 23 54 106 26 37 19 36 40 62 23 21
2021/2022257 9 12 28 6 18 30 2 22 14 13 28 75
2022/2023753 74 180 27 36 46 117 106 40 76 17 21 13
2023/2024342 10 43 52 12 30 70 18 70 4 33 0 0
Totale 2.591